SEC Form 4 · accession 0001415889-15-002519
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert N Fried
Director
Period of report
Jul 30, 2015
Accepted (ET)
Jul 31, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F1 | $1.10 | Jul 30, 2015 | A | 200,000 | A | Aug 30, 2015 | Jul 30, 2025 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Options vest 1/12th every month for 12 months and will be fully vested o July 30, 2016.